Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly (Q38160782)

30 August 2017

title

Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly (English)

1 reference

30 August 2017

Paolo Serafini

1

1 reference

30 August 2017

language of work or name

1 reference

1 December 2013

1 reference

30 August 2017

1 reference

30 August 2017

volume

57

1 reference

30 August 2017

issue

1-3

1 reference

30 August 2017

page(s)

172-184

1 reference

Natural Suppressor (NS) Cells, Neonatal Tolerance, and Total Lymphoid Irradiation: Exploring Obscure Relationships

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Myeloid-derived suppressor cells in cancer patients: a clinical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Myeloid-derived suppressor cell heterogeneity and subset definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Blood monocytes: development, heterogeneity, and relationship with dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Arginine metabolism: nitric oxide and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Nitric oxide and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

L-arginine availability regulates T-lymphocyte cell-cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

l-Arginine Deprivation Regulates Cyclin D3 mRNA Stability in Human T Cells by Controlling HuR Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Transcriptional regulation of macrophage polarization: enabling diversity with identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

The role of nitric oxide in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Regulation of immune responses by L-arginine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Nitric oxide and thiol redox regulation of Janus kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Nitric Oxide Regulation of Human Peripheral Blood Mononuclear Cells: Critical Time Dependence and Selectivity for Cytokine versus Chemokine Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Fas-induced caspase denitrosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Microenvironmental arginine depletion by macrophages in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Reactive oxygen species and 12/15-lipoxygenase contribute to the antiproliferative capacity of alternatively activated myeloid cells elicited during helminth infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Low membrane transport activity for cystine in resting and mitogenically stimulated human lymphocyte preparations and human T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Transport of cystine and cysteine in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Molecular pathways: tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Peroxynitrite reactivity with amino acids and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Cutting edge: bacterial infection induces hematopoietic stem and progenitor cell expansion in the absence of TLR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

TNF signaling drives myeloid-derived suppressor cell accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

NK cell response to vaccinia virus is regulated by myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Inflammatory cells of immunosuppressive phenotypes in oral lichen planus have a proinflammatory pattern of expression and are associated with clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Type 1 T Helper Cells Induce the Accumulation of Myeloid-Derived Suppressor Cells in the Inflamed Tgfb1 Knockout Mouse Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Differential effects of smoking and COPD upon circulating myeloid derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Inflammation in the context of oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Evasion of COPD in smokers: at what price?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Nonresolving inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Role of CXCL5 in leukocyte recruitment to the lungs during secondhand smoke exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Mechanistic links between COPD and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Oxidative stress in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Oxidative stress in expired breath condensate of patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Tumor escape mechanism governed by myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Myeloid cell diversification and complexity: an old concept with new turns in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Tumor-induced immune dysfunctions caused by myeloid suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Melanoma-induced immunosuppression and its neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Altered macrophage differentiation and immune dysfunction in tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Interleukin-6 increases expression and secretion of cathepsin B by breast tumor-associated monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1beta-dependent stabilization of Snail in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Immune tolerance to tumor antigens occurs in a specialized environment of the spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Peptide-conjugated PAMAM dendrimer as a universal DNA vaccine platform to target antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-013-8455-2

Periodontal diseases and cancer

21 January 2018

1 reference

12 December 2020

Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells

1 reference

12 December 2020

DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice

1 reference

12 December 2020

Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion

1 reference

12 December 2020

STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion

1 reference

12 December 2020

Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway

1 reference

12 December 2020

Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor

1 reference

12 December 2020

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

12 December 2020

Overexpression of arginase I in enterocytes of transgenic mice elicits a selective arginine deficiency and affects skin, muscle, and lymphoid development

1 reference

12 December 2020

In vivo induction of myeloid suppressor cells and CD4(+)Foxp3(+) T regulatory cells prolongs skin allograft survival in mice

1 reference

12 December 2020

A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma

1 reference

12 December 2020

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

1 reference

12 December 2020

Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells

1 reference

12 December 2020

Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.

1 reference

12 December 2020

Activation of cGMP-dependent protein kinase Ibeta inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells

1 reference

12 December 2020

Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer

1 reference

12 December 2020

Nitric Oxide-Independent CTL Suppression during Tumor Progression: Association with Arginase-Producing (M2) Myeloid Cells

1 reference

12 December 2020

Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species

1 reference

12 December 2020

Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway

1 reference

12 December 2020

Thiol-mediated redox regulation of lymphocyte proliferation. Possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression

1 reference

12 December 2020

Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer

1 reference

12 December 2020

Mast cell tryptase promotes breast cancer migration and invasion

1 reference

12 December 2020

Inducible nitric-oxide synthase generates superoxide from the reductase domain

1 reference

12 December 2020

Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

1 reference

12 December 2020

IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases

1 reference

12 December 2020

Staphylococcal exotoxins stimulate nitric oxide-dependent murine macrophage tumoricidal activity

1 reference

12 December 2020

Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor.

1 reference

12 December 2020

Poly(I:C) induce bone marrow precursor cells into myeloid-derived suppressor cells

1 reference

12 December 2020

Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells

1 reference

12 December 2020

Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity

1 reference

12 December 2020

10.1007/S12026-013-8455-2

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1032529572

0 references

1 reference